Načítá se...
Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer
BACKGROUND: The role of postoperative radiotherapy (PORT) in patients with clinical stage III-N2 (cIII-N2) non-small cell lung cancer (NSCLC) treated with induction chemotherapy and surgical resection with persistent ypN2 disease is not well-established. METHODS: We retrospectively reviewed a prospe...
Uloženo v:
| Vydáno v: | Ann Thorac Surg |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136648/ https://ncbi.nlm.nih.gov/pubmed/29807005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2018.04.064 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|